Researchers have found a new method to distinguish between Dementia with Lewy Bodies (DLB) and Alzheimer's Disease (AD) using vocal emotional expressions.
Dr Timothy Kwok, Professor at The Chinese University of Hong Kong, shares the development of the Electronic Cognitive Screen (EC-Screen) for population screening of dementia in older people.
JPND, the largest global collaborative initiative for neurodegenerative disease research, creates a major impact on neurodegenerative research funding in Europe.
Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.
Over 350 million people suffer from arthritis pain globally, which means significant levels of opiates are used to manage the condition - but what if there was a less addictive treatment?
Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.
Dementia UK’s Head of Research and Publications, Dr Karen Harrison Dening, discusses her thoughts on the diagnosis of dementia and the impact of COVID-19 on this.
Chairman for the global initiative EU Joint Programme – Neurodegenerative Disease Research (JPND) Professor Philippe Amouyel brings to light their innovative work in neurodegenerative disease research.
Therese Pei Fong Chow Research Centre for Prevention of Dementia, the Chinese University of Hong Kong, discuss if B vitamins can improve cognitive function in older people.
Shinichi Tokuno from Voice Analysis and Measurement of Pathophysiology, Department of Bioengineering, at the University of Tokyo, shares with us what we need to know about the detection of cognitive impairment with the benefit of voice analysis technology concerning the ageing of people globally.
Open Access Government delve into the CBD oil revolution in this introduction to CBD which explores the difference between CBD and THC, as well as a range of benefits and safety precautions for cannabidiol use in cancer patients and pregnant women.
The work of the Centers for Disease Control and Prevention, within the U.S. Department of Health & Human Services is examined here, with a special focus on traumatic brain injury.
